AirSculpt Technologies, Inc. Common Stock

Day range

$0.65 – $1.02

Open

$0.99

Prev close

$1.44

Volume

2.02M

Market cap

$103.82M

Shares out

72.1M

P/E

—

P/S

0.69

P/B

0.99

P/FCF

136.60

ROE

-11.2%

ROA

-6.1%

Debt/Equity

0.42

Div yield

0.00%

As of Nov 5, 2026

• Annual meeting resultsMay 14, 2026

  At the Annual Meeting, the Company's stockholders were asked (i) to elect three Class II director nominees to the Company's Board of Directors (the "Board"), each to hold office until the 2029 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier resignation or removal, and (ii) to ratify the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Adam Feinstein, Thomas Aaron, and Kenneth Higgins were duly elected to the Company's Board as Class II directors to serve until the 2029 annual meeting of stockholders.

• Preliminary resultsMar 16, 2026

  AirSculpt Technologies, Inc. (the "Company") issued a press release announcing certain preliminary, unaudited financial information for the fourth quarter and full fiscal year ended December 31, 2025.

• Director appointmentNov 18, 2025

  On November 14, 2025, the board of directors (the "Board") of AirSculpt Technologies, Inc. (the "Company") elected Michael Doyle to serve as a Class III director of the Board and as the Non-Executive Chairman of the Board, in each case effective as of the same date. Mr. Doyle has served as Managing Partner of Vesey Street Capital Partners since January 2025. Mr. Doyle founded MD Healthcare Partners in 2018 and served as its Chief Executive Officer until December 2024. Previously, Mr. Doyle held several leadership positions, including Chief Executive Officer from 2009 to September 2017, at Surgery Partners (NASDAQ: SGRY).

• Cfo appointmentNov 7, 2025

  On November 7, 2025, the Company announced that it has hired Michael Arthur, 38, to serve as the Company's Chief Financial Officer, effective January 5, 2026. Prior to joining the Company, Mr. Arthur served as the Chief Financial Officer of Inspirato Incorporated from October 2024 to January 2026, and as Senior Vice President, Finance, and Vice President of FP&A and Treasury, of Inspirato Incorporated from February 2023 to September 2024.

• Executive officer departureNov 5, 2025

  On November 4, 2025, Dr. Aaron Rollins resigned as executive chairman of the board of directors (the "Board") of AirSculpt Technologies, Inc. (the "Company") and as a member of the Board, effective as of November 4, 2025. Dr. Rollins' resignation was not due to any disagreements between him and the Company, its management, or the Board on any matter relating to the Company's operations, policies or practices.

Days to cover

3.5

Short interest

2.95M

Avg volume

855.18K

As of Oct 15, 2026 · reported to FINRA twice monthly.

• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
  negativeGlobeNewswire Inc.· Oct 6, 2026
• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Securitize Corp. – SECZ
  negativeGlobeNewswire Inc.· Oct 6, 2026
• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
  negativeGlobeNewswire Inc.· Sep 1, 2026
• AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board
  positiveGlobeNewswire Inc.· Nov 17, 2025
• AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results
  neutralGlobeNewswire Inc.· Aug 1, 2025